Skip to main content
Top
Published in: Clinical Reviews in Allergy & Immunology 1/2011

01-02-2011

The Unexplained Female Predominance of Systemic Lupus Erythematosus: Clues from Genetic and Cytokine Studies

Authors: Corinna E. Weckerle, Timothy B. Niewold

Published in: Clinical Reviews in Allergy & Immunology | Issue 1/2011

Login to get access

Abstract

Despite recent progress in the understanding of systemic lupus erythematosus (SLE), the striking 9:1 female to male ratio of disease incidence remains largely unexplained. In addition, peak SLE incidence rates occur during the early reproductive years in women. Studies which illuminate potential causes underlying this sex difference and characteristic onset during the reproductive years have the potential to fundamentally advance our understanding of disease pathogenesis in SLE. Similarly, progress in this area will likely inform human reproductive immunology. Studies of sex hormone function in the immune system are of obvious importance; however, it seems likely that many other types of sex-related genetic and immunological differences will contribute to SLE. In this review, we will focus on recent work in sex-related differences in cytokine pathways and genetics of these pathways as they relate to SLE pathogenesis. It seems quite possible that many of these sex-related differences could be important to reproductive fitness, which may explain the conservation of these immune system features and the observed female predominance of SLE.
Literature
2.
go back to reference Petri M (2002) Epidemiology of systemic lupus erythematosus. Best Pract Res Clin Rheumatol 16(5):847–858CrossRefPubMed Petri M (2002) Epidemiology of systemic lupus erythematosus. Best Pract Res Clin Rheumatol 16(5):847–858CrossRefPubMed
3.
go back to reference Rus V, Maury EE, Hochberg MC (eds) (2002) The epidemiology of systemic lupus erythematosus. Williams and Wilkins, Philadelphia Rus V, Maury EE, Hochberg MC (eds) (2002) The epidemiology of systemic lupus erythematosus. Williams and Wilkins, Philadelphia
4.
go back to reference Chakravarty EF, Bush TM, Manzi S, Clarke AE, Ward MM (2007) Prevalence of adult systemic lupus erythematosus in California and Pennsylvania in 2000: estimates obtained using hospitalization data. Arthritis Rheum 56(6):2092–2094CrossRefPubMed Chakravarty EF, Bush TM, Manzi S, Clarke AE, Ward MM (2007) Prevalence of adult systemic lupus erythematosus in California and Pennsylvania in 2000: estimates obtained using hospitalization data. Arthritis Rheum 56(6):2092–2094CrossRefPubMed
5.
go back to reference Lopez P, Mozo L, Gutierrez C, Suarez A (2003) Epidemiology of systemic lupus erythematosus in a northern Spanish population: gender and age influence on immunological features. Lupus 12(11):860–865CrossRefPubMed Lopez P, Mozo L, Gutierrez C, Suarez A (2003) Epidemiology of systemic lupus erythematosus in a northern Spanish population: gender and age influence on immunological features. Lupus 12(11):860–865CrossRefPubMed
6.
go back to reference Bazer FW STE, Johnson GA, Burghardt RC, Wu G (2009) Comparative aspects of implantation. Reproduction 138(2):195–209 Bazer FW STE, Johnson GA, Burghardt RC, Wu G (2009) Comparative aspects of implantation. Reproduction 138(2):195–209
7.
go back to reference Szyper-Kravitz M, Zandman-Goddard G, Lahita RG, Shoenfeld Y (2005) The neuroendocrine-immune interactions in systemic lupus erythematosus: a basis for understanding disease pathogenesis and complexity. Rheum Dis Clin North Am 31(1):161–175, xCrossRefPubMed Szyper-Kravitz M, Zandman-Goddard G, Lahita RG, Shoenfeld Y (2005) The neuroendocrine-immune interactions in systemic lupus erythematosus: a basis for understanding disease pathogenesis and complexity. Rheum Dis Clin North Am 31(1):161–175, xCrossRefPubMed
8.
go back to reference Stevens AM, Tsao BP, Hahn BH, Guthrie K, Lambert NC, Porter AJ et al (2005) Maternal HLA class II compatibility in men with systemic lupus erythematosus. Arthritis Rheum 52(9):2768–2773CrossRefPubMed Stevens AM, Tsao BP, Hahn BH, Guthrie K, Lambert NC, Porter AJ et al (2005) Maternal HLA class II compatibility in men with systemic lupus erythematosus. Arthritis Rheum 52(9):2768–2773CrossRefPubMed
9.
go back to reference Chagnon P, Schneider R, Hebert J, Fortin PR, Provost S, Belisle C et al (2006) Identification and characterization of an Xp22.33;Yp11.2 translocation causing a triplication of several genes of the pseudoautosomal region 1 in an XX male patient with severe systemic lupus erythematosus. Arthritis Rheum 54(4):1270–1278CrossRefPubMed Chagnon P, Schneider R, Hebert J, Fortin PR, Provost S, Belisle C et al (2006) Identification and characterization of an Xp22.33;Yp11.2 translocation causing a triplication of several genes of the pseudoautosomal region 1 in an XX male patient with severe systemic lupus erythematosus. Arthritis Rheum 54(4):1270–1278CrossRefPubMed
10.
go back to reference Sawalha AH, Webb R, Han S, Kelly JA, Kaufman KM, Kimberly RP et al (2008) Common variants within MECP2 confer risk of systemic lupus erythematosus. PLoS ONE 3(3):e1727CrossRefPubMed Sawalha AH, Webb R, Han S, Kelly JA, Kaufman KM, Kimberly RP et al (2008) Common variants within MECP2 confer risk of systemic lupus erythematosus. PLoS ONE 3(3):e1727CrossRefPubMed
11.
go back to reference Jacob CO, Zhu J, Armstrong DL, Yan M, Han J et al (2009) Identification of IRAK1 as a risk gene with critical role in the pathogenesis of systemic lupus erythematosus. PNAS 106(15):6256–6261CrossRefPubMed Jacob CO, Zhu J, Armstrong DL, Yan M, Han J et al (2009) Identification of IRAK1 as a risk gene with critical role in the pathogenesis of systemic lupus erythematosus. PNAS 106(15):6256–6261CrossRefPubMed
12.
go back to reference Forton AC, Petri MA, Goldman D, Sullivan KE (2002) An osteopontin (SPP1) polymorphism is associated with systemic lupus erythematosus. Hum Mutat 19(4):459CrossRefPubMed Forton AC, Petri MA, Goldman D, Sullivan KE (2002) An osteopontin (SPP1) polymorphism is associated with systemic lupus erythematosus. Hum Mutat 19(4):459CrossRefPubMed
13.
go back to reference D'Alfonso S, Barizzone N, Giordano M, Chiocchetti A, Magnani C, Castelli L et al (2005) Two single-nucleotide polymorphisms in the 5′ and 3′ ends of the osteopontin gene contribute to susceptibility to systemic lupus erythematosus. Arthritis Rheum 52(2):539–547CrossRefPubMed D'Alfonso S, Barizzone N, Giordano M, Chiocchetti A, Magnani C, Castelli L et al (2005) Two single-nucleotide polymorphisms in the 5′ and 3′ ends of the osteopontin gene contribute to susceptibility to systemic lupus erythematosus. Arthritis Rheum 52(2):539–547CrossRefPubMed
14.
go back to reference Han S, Guthridge JM, Harley IT, Sestak AL, Kim-Howard X, Kaufman KM et al (2008) Osteopontin and systemic lupus erythematosus association: a probable gene–gender interaction. PLoS ONE 3(3):e0001757CrossRefPubMed Han S, Guthridge JM, Harley IT, Sestak AL, Kim-Howard X, Kaufman KM et al (2008) Osteopontin and systemic lupus erythematosus association: a probable gene–gender interaction. PLoS ONE 3(3):e0001757CrossRefPubMed
15.
go back to reference Blanco P, Palucka AK, Gill M, Pascual V, Banchereau J (2001) Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science 294(5546):1540–1543CrossRefPubMed Blanco P, Palucka AK, Gill M, Pascual V, Banchereau J (2001) Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science 294(5546):1540–1543CrossRefPubMed
16.
go back to reference Hooks JJ, Moutsopoulos HM, Geis SA, Stahl NI, Decker JL, Notkins AL (1979) Immune interferon in the circulation of patients with autoimmune disease. N Engl J Med 301(1):5–8CrossRefPubMed Hooks JJ, Moutsopoulos HM, Geis SA, Stahl NI, Decker JL, Notkins AL (1979) Immune interferon in the circulation of patients with autoimmune disease. N Engl J Med 301(1):5–8CrossRefPubMed
17.
go back to reference Kirou KA, Lee C, George S, Louca K, Peterson MG, Crow MK (2005) Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease. Arthritis Rheum 52(5):1491–1503CrossRefPubMed Kirou KA, Lee C, George S, Louca K, Peterson MG, Crow MK (2005) Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease. Arthritis Rheum 52(5):1491–1503CrossRefPubMed
18.
go back to reference Ronnblom LE, Alm GV, Oberg KE (1990) Possible induction of systemic lupus erythematosus by interferon-alpha treatment in a patient with a malignant carcinoid tumour. J Intern Med 227(3):207–210CrossRefPubMed Ronnblom LE, Alm GV, Oberg KE (1990) Possible induction of systemic lupus erythematosus by interferon-alpha treatment in a patient with a malignant carcinoid tumour. J Intern Med 227(3):207–210CrossRefPubMed
19.
go back to reference Niewold TB, Swedler WI (2005) Systemic lupus erythematosus arising during interferon-alpha therapy for cryoglobulinemic vasculitis associated with hepatitis C. Clin Rheumatol 24(2):178–181CrossRefPubMed Niewold TB, Swedler WI (2005) Systemic lupus erythematosus arising during interferon-alpha therapy for cryoglobulinemic vasculitis associated with hepatitis C. Clin Rheumatol 24(2):178–181CrossRefPubMed
20.
go back to reference Niewold TB (2008) Interferon alpha-induced lupus: proof of principle. J Clin Rheumatol 14(3):131–132CrossRefPubMed Niewold TB (2008) Interferon alpha-induced lupus: proof of principle. J Clin Rheumatol 14(3):131–132CrossRefPubMed
21.
go back to reference Niewold TB, Hua J, Lehman TJ, Harley JB, Crow MK (2007) High serum IFN-alpha activity is a heritable risk factor for systemic lupus erythematosus. Genes Immun 8:492–502CrossRefPubMed Niewold TB, Hua J, Lehman TJ, Harley JB, Crow MK (2007) High serum IFN-alpha activity is a heritable risk factor for systemic lupus erythematosus. Genes Immun 8:492–502CrossRefPubMed
22.
go back to reference Niewold TB, Adler JE, Glenn SB, Lehman TJ, Harley JB, Crow MK (2008) Age- and sex-related patterns of serum interferon-alpha activity in lupus families. Arthritis Rheum 58(7):2113–2119CrossRefPubMed Niewold TB, Adler JE, Glenn SB, Lehman TJ, Harley JB, Crow MK (2008) Age- and sex-related patterns of serum interferon-alpha activity in lupus families. Arthritis Rheum 58(7):2113–2119CrossRefPubMed
23.
go back to reference Kariuki SN, Niewold TB. Genetic regulation of serum cytokines in systemic lupus erythematosus. Transl Res 2009, In press Kariuki SN, Niewold TB. Genetic regulation of serum cytokines in systemic lupus erythematosus. Transl Res 2009, In press
24.
go back to reference Niewold TB, Kelly JA, Flesch MH, Espinoza LR, Harley JB, Crow MK (2008) Association of the IRF5 risk haplotype with high serum interferon-alpha activity in systemic lupus erythematosus patients. Arthritis Rheum 58(8):2481–2487CrossRefPubMed Niewold TB, Kelly JA, Flesch MH, Espinoza LR, Harley JB, Crow MK (2008) Association of the IRF5 risk haplotype with high serum interferon-alpha activity in systemic lupus erythematosus patients. Arthritis Rheum 58(8):2481–2487CrossRefPubMed
25.
go back to reference Salloum R, Franek BS, Kariuki SN, Rhee L, Mikolaitis RA, Jolly M et al Genetic variation at the IRF7/PHRF1 locus is associated with autoantibody profile and serum interferon alpha activity in lupus patients. Arthritis Rheum 2009, In press Salloum R, Franek BS, Kariuki SN, Rhee L, Mikolaitis RA, Jolly M et al Genetic variation at the IRF7/PHRF1 locus is associated with autoantibody profile and serum interferon alpha activity in lupus patients. Arthritis Rheum 2009, In press
26.
go back to reference Kariuki SN, Crow MK, Niewold TB (2008) The PTPN22 C1858T polymorphism is associated with skewing of cytokine profiles toward high interferon-alpha activity and low tumor necrosis factor alpha levels in patients with lupus. Arthritis Rheum 58(9):2818–2823CrossRefPubMed Kariuki SN, Crow MK, Niewold TB (2008) The PTPN22 C1858T polymorphism is associated with skewing of cytokine profiles toward high interferon-alpha activity and low tumor necrosis factor alpha levels in patients with lupus. Arthritis Rheum 58(9):2818–2823CrossRefPubMed
27.
go back to reference Kariuki SN, Moore JG, Kirou KA, Crow MK, Utset TO, Niewold TB (2009) Age- and gender-specific modulation of serum osteopontin and interferon-alpha by osteopontin genotype in systemic lupus erythematosus. Genes Immun 10(5):487–494CrossRefPubMed Kariuki SN, Moore JG, Kirou KA, Crow MK, Utset TO, Niewold TB (2009) Age- and gender-specific modulation of serum osteopontin and interferon-alpha by osteopontin genotype in systemic lupus erythematosus. Genes Immun 10(5):487–494CrossRefPubMed
28.
go back to reference Kariuki SN, Kirou KA, MacDermott EJ, Barillas-Arias L, Crow MK, Niewold TB (2009) Cutting edge: autoimmune disease risk variant of STAT4 confers increased sensitivity to IFN-alpha in lupus patients in vivo. J Immunol 182(1):34–38PubMed Kariuki SN, Kirou KA, MacDermott EJ, Barillas-Arias L, Crow MK, Niewold TB (2009) Cutting edge: autoimmune disease risk variant of STAT4 confers increased sensitivity to IFN-alpha in lupus patients in vivo. J Immunol 182(1):34–38PubMed
29.
go back to reference Pestka S, Krause CD, Walter MR (2004) Interferons, interferon-like cytokines, and their receptors. Immunol Rev 202:8–32CrossRefPubMed Pestka S, Krause CD, Walter MR (2004) Interferons, interferon-like cytokines, and their receptors. Immunol Rev 202:8–32CrossRefPubMed
30.
go back to reference Bazer FW WG, Spencer TE, Johnson GA, Burghardt RC, Bayless K. Novel Pathways for Implantation and Establishment and Maintenance of Pregnancy in Mammals. Mol Hum Reprod 2009 Bazer FW WG, Spencer TE, Johnson GA, Burghardt RC, Bayless K. Novel Pathways for Implantation and Establishment and Maintenance of Pregnancy in Mammals. Mol Hum Reprod 2009
31.
go back to reference Johnson GA, Bazer FW, Burghardt RC, Spencer TE, Wu G, Bayless KJ (2009) Conceptus-uterus interactions in pigs: endometrial gene expression in response to estrogens and interferons from conceptuses. Soc Reprod Fertil 66(Suppl):321–332 Johnson GA, Bazer FW, Burghardt RC, Spencer TE, Wu G, Bayless KJ (2009) Conceptus-uterus interactions in pigs: endometrial gene expression in response to estrogens and interferons from conceptuses. Soc Reprod Fertil 66(Suppl):321–332
32.
go back to reference Peeva E, Grimaldi C, Spatz L, Diamond B (2000) Bromocriptine restores tolerance in estrogen-treated mice. J Clin Invest 106(11):1373–1379CrossRefPubMed Peeva E, Grimaldi C, Spatz L, Diamond B (2000) Bromocriptine restores tolerance in estrogen-treated mice. J Clin Invest 106(11):1373–1379CrossRefPubMed
33.
go back to reference Hughes GC, Clark EA (2007) Regulation of dendritic cells by female sex steroids: relevance to immunity and autoimmunity. Autoimmunity 40(6):470–481CrossRefPubMed Hughes GC, Clark EA (2007) Regulation of dendritic cells by female sex steroids: relevance to immunity and autoimmunity. Autoimmunity 40(6):470–481CrossRefPubMed
34.
go back to reference Siracusa MC, Overstreet MG, Housseau F, Scott AL, Klein SL (2008) 17beta-estradiol alters the activity of conventional and IFN-producing killer dendritic cells. J Immunol 180(3):1423–1431PubMed Siracusa MC, Overstreet MG, Housseau F, Scott AL, Klein SL (2008) 17beta-estradiol alters the activity of conventional and IFN-producing killer dendritic cells. J Immunol 180(3):1423–1431PubMed
35.
go back to reference Hughes GC, Thomas S, Li C, Kaja MK, Clark EA (2008) Cutting edge: progesterone regulates IFN-alpha production by plasmacytoid dendritic cells. J Immunol 180(4):2029–2033PubMed Hughes GC, Thomas S, Li C, Kaja MK, Clark EA (2008) Cutting edge: progesterone regulates IFN-alpha production by plasmacytoid dendritic cells. J Immunol 180(4):2029–2033PubMed
36.
go back to reference Lahita RG (1999) The role of sex hormones in systemic lupus erythematosus. Curr Opin Rheumatol 11(5):352–356CrossRefPubMed Lahita RG (1999) The role of sex hormones in systemic lupus erythematosus. Curr Opin Rheumatol 11(5):352–356CrossRefPubMed
37.
go back to reference Doria A, Cutolo M, Ghirardello A, Zampieri S, Vescovi F, Sulli A et al (2002) Steroid hormones and disease activity during pregnancy in systemic lupus erythematosus. Arthritis Rheum 47(2):202–209CrossRefPubMed Doria A, Cutolo M, Ghirardello A, Zampieri S, Vescovi F, Sulli A et al (2002) Steroid hormones and disease activity during pregnancy in systemic lupus erythematosus. Arthritis Rheum 47(2):202–209CrossRefPubMed
38.
go back to reference Nalbandian G, Kovats S (2005) Understanding sex biases in immunity: effects of estrogen on the differentiation and function of antigen-presenting cells. Immunol Res 31(2):91–106CrossRefPubMed Nalbandian G, Kovats S (2005) Understanding sex biases in immunity: effects of estrogen on the differentiation and function of antigen-presenting cells. Immunol Res 31(2):91–106CrossRefPubMed
39.
go back to reference Zandman-Goddard G, Peeva E, Shoenfeld Y (2007) Gender and autoimmunity. Autoimmun Rev 6(6):366–372CrossRefPubMed Zandman-Goddard G, Peeva E, Shoenfeld Y (2007) Gender and autoimmunity. Autoimmun Rev 6(6):366–372CrossRefPubMed
40.
go back to reference Drexler SK, Foxwell BM (2009) The role of Toll-like receptors in chronic inflammation. Int J Biochem Cell Biol Drexler SK, Foxwell BM (2009) The role of Toll-like receptors in chronic inflammation. Int J Biochem Cell Biol
41.
go back to reference Ronnblom L, Alm GV, Eloranta ML (2009) Type I interferon and lupus. Curr Opin Rheumatol 21(5):471–477CrossRefPubMed Ronnblom L, Alm GV, Eloranta ML (2009) Type I interferon and lupus. Curr Opin Rheumatol 21(5):471–477CrossRefPubMed
42.
go back to reference Izui S (1990) Autoimmune accelerating genes, lpr and Yaa, in murine systemic lupus erythematosus. Autoimmunity 6(1–2):113–129CrossRefPubMed Izui S (1990) Autoimmune accelerating genes, lpr and Yaa, in murine systemic lupus erythematosus. Autoimmunity 6(1–2):113–129CrossRefPubMed
43.
go back to reference Subramanian S, Tus K, Li QZ, Wang A, Tian XH, Zhou J et al (2006) A Tlr7 translocation accelerates systemic autoimmunity in murine lupus. Proc Natl Acad Sci USA 103(26):9970–9975CrossRefPubMed Subramanian S, Tus K, Li QZ, Wang A, Tian XH, Zhou J et al (2006) A Tlr7 translocation accelerates systemic autoimmunity in murine lupus. Proc Natl Acad Sci USA 103(26):9970–9975CrossRefPubMed
44.
go back to reference Pisitkun P, Deane J, Difilippantonio M, Tarasenko T, Satterthwaite A, Bolland S (2006) Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science 312:1669–1672CrossRefPubMed Pisitkun P, Deane J, Difilippantonio M, Tarasenko T, Satterthwaite A, Bolland S (2006) Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science 312:1669–1672CrossRefPubMed
45.
go back to reference Berghofer B, Frommer T, Haley G, Fink L, Bein G, Hackstein H (2006) TLR7 ligands induce higher IFN-alpha production in females. J Immunol 177(4):2088–2096PubMed Berghofer B, Frommer T, Haley G, Fink L, Bein G, Hackstein H (2006) TLR7 ligands induce higher IFN-alpha production in females. J Immunol 177(4):2088–2096PubMed
46.
go back to reference Visentini M, Conti V, Cagliuso M, Tinti F, Siciliano G, Trombetta AC et al (2009) Regression of systemic lupus erythematosus after development of an acquired Toll-like receptor signaling defect and antibody deficiency. Arthritis Rheum 60(9):2767–2771CrossRefPubMed Visentini M, Conti V, Cagliuso M, Tinti F, Siciliano G, Trombetta AC et al (2009) Regression of systemic lupus erythematosus after development of an acquired Toll-like receptor signaling defect and antibody deficiency. Arthritis Rheum 60(9):2767–2771CrossRefPubMed
47.
go back to reference Kelley J, Johnson MR, Alarcon GS, Kimberly RP, Edberg JC (2007) Variation in the relative copy number of the TLR7 gene in patients with systemic lupus erythematosus and healthy control subjects. Arthritis Rheum 56(10):3375–3378CrossRefPubMed Kelley J, Johnson MR, Alarcon GS, Kimberly RP, Edberg JC (2007) Variation in the relative copy number of the TLR7 gene in patients with systemic lupus erythematosus and healthy control subjects. Arthritis Rheum 56(10):3375–3378CrossRefPubMed
48.
go back to reference Jimenez SA, Artlett CM (2005) Microchimerism and systemic sclerosis. Curr Opin Rheumatol 17(1):86–90CrossRefPubMed Jimenez SA, Artlett CM (2005) Microchimerism and systemic sclerosis. Curr Opin Rheumatol 17(1):86–90CrossRefPubMed
49.
go back to reference Lambert NC, Stevens AM, Tylee TS, Erickson TD, Furst DE, Nelson JL (2001) From the simple detection of microchimerism in patients with autoimmune diseases to its implication in pathogenesis. Ann NY Acad Sci 945:164–171CrossRefPubMed Lambert NC, Stevens AM, Tylee TS, Erickson TD, Furst DE, Nelson JL (2001) From the simple detection of microchimerism in patients with autoimmune diseases to its implication in pathogenesis. Ann NY Acad Sci 945:164–171CrossRefPubMed
50.
go back to reference Johnson KL, McAlindon TE, Mulcahy E, Bianchi DW (2001) Microchimerism in a female patient with systemic lupus erythematosus. Arthritis Rheum 44(9):2107–2111CrossRefPubMed Johnson KL, McAlindon TE, Mulcahy E, Bianchi DW (2001) Microchimerism in a female patient with systemic lupus erythematosus. Arthritis Rheum 44(9):2107–2111CrossRefPubMed
51.
go back to reference Kremer Hovinga IC, Koopmans M, Grootscholten C, van der Wal AM, Bijl M, Derksen RH et al (2008) Pregnancy, chimerism and lupus nephritis: a multi-centre study. Lupus 17(6):541–547CrossRefPubMed Kremer Hovinga IC, Koopmans M, Grootscholten C, van der Wal AM, Bijl M, Derksen RH et al (2008) Pregnancy, chimerism and lupus nephritis: a multi-centre study. Lupus 17(6):541–547CrossRefPubMed
52.
go back to reference Reed A, Picnorell YJ, Harwood A, Kredich D (2000) Chimerism in children with juvenile dermatomyositis. Lancet 356:2156–2157CrossRefPubMed Reed A, Picnorell YJ, Harwood A, Kredich D (2000) Chimerism in children with juvenile dermatomyositis. Lancet 356:2156–2157CrossRefPubMed
53.
go back to reference Artlett CM, Ramos R, Jiminez SA, Patterson K, Miller FW, Rider LG, the Childhood Myositis Heterogeneity Collaborative Group (2000) Chimeric cells of maternal origin in juvenile idiopathic inflammatory myopathies. Lancet 356:2155–2156CrossRefPubMed Artlett CM, Ramos R, Jiminez SA, Patterson K, Miller FW, Rider LG, the Childhood Myositis Heterogeneity Collaborative Group (2000) Chimeric cells of maternal origin in juvenile idiopathic inflammatory myopathies. Lancet 356:2155–2156CrossRefPubMed
54.
go back to reference Stevens AM, Hermes HM, Rutledge JC, Buyon JP, Nelson JL (2000) Myocardial-tissue-specific phenotype of maternal microchimerism in neonatal lupus congenital heart block. Lancet 362:1617–1623CrossRef Stevens AM, Hermes HM, Rutledge JC, Buyon JP, Nelson JL (2000) Myocardial-tissue-specific phenotype of maternal microchimerism in neonatal lupus congenital heart block. Lancet 362:1617–1623CrossRef
55.
go back to reference Walsh RJ, Kong SW, Yao Y, Jallal B, Kiener PA, Pinkus JL et al (2007) Type I interferon-inducible gene expression in blood is present and reflects disease activity in dermatomyositis and polymyositis. Arthritis Rheum 56(11):3784–3792CrossRefPubMed Walsh RJ, Kong SW, Yao Y, Jallal B, Kiener PA, Pinkus JL et al (2007) Type I interferon-inducible gene expression in blood is present and reflects disease activity in dermatomyositis and polymyositis. Arthritis Rheum 56(11):3784–3792CrossRefPubMed
56.
go back to reference Niewold TB, Kariuki SN, Morgan GA, Shrestha S, Pachman LM (2009) Elevated serum interferon-alpha activity in juvenile dermatomyositis: associations with disease activity at diagnosis and after thirty-six months of therapy. Arthritis Rheum 60(6):1815–1824CrossRefPubMed Niewold TB, Kariuki SN, Morgan GA, Shrestha S, Pachman LM (2009) Elevated serum interferon-alpha activity in juvenile dermatomyositis: associations with disease activity at diagnosis and after thirty-six months of therapy. Arthritis Rheum 60(6):1815–1824CrossRefPubMed
57.
go back to reference Niewold TB, Rivera TL, Buyon JP, Crow MK (2008) Serum type I interferon activity is dependent on maternal diagnosis in anti-SSA/Ro-positive mothers of children with neonatal lupus. Arthritis Rheum 58(2):541–546CrossRefPubMed Niewold TB, Rivera TL, Buyon JP, Crow MK (2008) Serum type I interferon activity is dependent on maternal diagnosis in anti-SSA/Ro-positive mothers of children with neonatal lupus. Arthritis Rheum 58(2):541–546CrossRefPubMed
58.
go back to reference Stevens AM (2006) Microchimeric cells in systemic lupus erythematosus: targets or innocent bystanders? Lupus 15(11):820–826CrossRefPubMed Stevens AM (2006) Microchimeric cells in systemic lupus erythematosus: targets or innocent bystanders? Lupus 15(11):820–826CrossRefPubMed
59.
go back to reference Larizza D, Calcaterra V, Martinetti M (2009) Autoimmune stigmata in Turner syndrome: when lacks an X chromosome. J Autoimmun 33(1):25–30CrossRefPubMed Larizza D, Calcaterra V, Martinetti M (2009) Autoimmune stigmata in Turner syndrome: when lacks an X chromosome. J Autoimmun 33(1):25–30CrossRefPubMed
60.
go back to reference Invernizzi P, Miozzo M, Selmi C, Persani L, Battezzati P, Zuin M et al (2005) X chromosome monosomy: a common mechanism for autoimmune disease. J Immunol 175:575–578PubMed Invernizzi P, Miozzo M, Selmi C, Persani L, Battezzati P, Zuin M et al (2005) X chromosome monosomy: a common mechanism for autoimmune disease. J Immunol 175:575–578PubMed
61.
go back to reference Invernizzi P, Miozzo M, Oertelt-Prigione S, Meroni PL, Persani L, Selmi C et al (2007) X monosomy in female systemic lupus erythematosus. Ann NY Acad Sci 1110:84–91CrossRefPubMed Invernizzi P, Miozzo M, Oertelt-Prigione S, Meroni PL, Persani L, Selmi C et al (2007) X monosomy in female systemic lupus erythematosus. Ann NY Acad Sci 1110:84–91CrossRefPubMed
62.
go back to reference Cooney CM, Bruner GR, Aberle T, Namjou-Khales B, Myers LK, Feo L et al (2009) 46, X, del(X)(q13) Turner's syndrome women with systemic lupus erythematosus in a pedigree multiplex for SLE. Genes Immun 10(5):478–481CrossRefPubMed Cooney CM, Bruner GR, Aberle T, Namjou-Khales B, Myers LK, Feo L et al (2009) 46, X, del(X)(q13) Turner's syndrome women with systemic lupus erythematosus in a pedigree multiplex for SLE. Genes Immun 10(5):478–481CrossRefPubMed
63.
go back to reference Scofield RH, Bruner GR, Namjou B, Kimberly RP, Ramsey-Goldman R, Petri M et al (2008) Klinefelter's syndrome (47,XXY) in male systemic lupus erythematosus patients: support for the notion of a gene-dose effect from the X chromosome. Arthritis Rheum 58(8):2511–2517CrossRefPubMed Scofield RH, Bruner GR, Namjou B, Kimberly RP, Ramsey-Goldman R, Petri M et al (2008) Klinefelter's syndrome (47,XXY) in male systemic lupus erythematosus patients: support for the notion of a gene-dose effect from the X chromosome. Arthritis Rheum 58(8):2511–2517CrossRefPubMed
64.
go back to reference Ozbalkan Z, Bagislar S, Kiraz S, Akyerli CB, Ozer HT, Yavuz S et al (2005) Skewed X chromosome inactivation in blood cells of women with scleroderma. Arthritis Rheum 52(5):1564–1570CrossRefPubMed Ozbalkan Z, Bagislar S, Kiraz S, Akyerli CB, Ozer HT, Yavuz S et al (2005) Skewed X chromosome inactivation in blood cells of women with scleroderma. Arthritis Rheum 52(5):1564–1570CrossRefPubMed
65.
go back to reference Ozcelik T, Uz E, Akyerli CB, Bagislar S, Mustafa CA, Gursoy A et al (2006) Evidence from autoimmune thyroiditis of skewed X-chromosome inactivation in female predisposition to autoimmunity. Eur J Hum Genet 14(6):791–797CrossRefPubMed Ozcelik T, Uz E, Akyerli CB, Bagislar S, Mustafa CA, Gursoy A et al (2006) Evidence from autoimmune thyroiditis of skewed X-chromosome inactivation in female predisposition to autoimmunity. Eur J Hum Genet 14(6):791–797CrossRefPubMed
66.
go back to reference Invernizzi P, Pasini S, Selmi C, Miozzo M, Podda M (2008) Skewing of X chromosome inactivation in autoimmunity. Autoimmunity 41(4):272–277CrossRefPubMed Invernizzi P, Pasini S, Selmi C, Miozzo M, Podda M (2008) Skewing of X chromosome inactivation in autoimmunity. Autoimmunity 41(4):272–277CrossRefPubMed
67.
go back to reference Chitnis S, Monteiro J, Glass D, Apatoff B, Salmon J, Concannon P et al (2000) The role of X-chromosome inactivation in female predisposition to autoimmunity. Arthritis Res 2:399–406CrossRefPubMed Chitnis S, Monteiro J, Glass D, Apatoff B, Salmon J, Concannon P et al (2000) The role of X-chromosome inactivation in female predisposition to autoimmunity. Arthritis Res 2:399–406CrossRefPubMed
68.
go back to reference Pan Y, Sawalha AH (2009) Epigenetic regulation and the pathogenesis of systemic lupus erythematosus. Transl Res 153(1):4–10CrossRefPubMed Pan Y, Sawalha AH (2009) Epigenetic regulation and the pathogenesis of systemic lupus erythematosus. Transl Res 153(1):4–10CrossRefPubMed
69.
go back to reference Shinohara ML, Lu L, Bu J, Werneck MB, Kobayashi KS, Glimcher LH et al (2006) Osteopontin expression is essential for interferon-alpha production by plasmacytoid dendritic cells. Nat Immunol 7(5):498–506CrossRefPubMed Shinohara ML, Lu L, Bu J, Werneck MB, Kobayashi KS, Glimcher LH et al (2006) Osteopontin expression is essential for interferon-alpha production by plasmacytoid dendritic cells. Nat Immunol 7(5):498–506CrossRefPubMed
70.
go back to reference Masutani K, Akahoshi M, Tsuruya K, Tokumoto M, Ninomiya T, Kohsaka T et al (2001) Predominance of Th1 immune response in diffuse proliferative lupus nephritis. Arthritis Rheum 44(9):2097–2106CrossRefPubMed Masutani K, Akahoshi M, Tsuruya K, Tokumoto M, Ninomiya T, Kohsaka T et al (2001) Predominance of Th1 immune response in diffuse proliferative lupus nephritis. Arthritis Rheum 44(9):2097–2106CrossRefPubMed
71.
go back to reference Chabas D, Baranzini SE, Mitchell D, Bernard CC, Rittling SR, Denhardt DT et al (2001) The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science 294(5547):1731–1735CrossRefPubMed Chabas D, Baranzini SE, Mitchell D, Bernard CC, Rittling SR, Denhardt DT et al (2001) The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science 294(5547):1731–1735CrossRefPubMed
72.
go back to reference Denhardt DT, Noda M (1998) Osteopontin expression and function: role in bone remodeling. J Cell Biochem Suppl 30–31:92–102CrossRefPubMed Denhardt DT, Noda M (1998) Osteopontin expression and function: role in bone remodeling. J Cell Biochem Suppl 30–31:92–102CrossRefPubMed
73.
go back to reference Vanacker JM, Delmarre C, Guo X, Laudet V (1998) Activation of the osteopontin promoter by the orphan nuclear receptor estrogen receptor related alpha. Cell Growth Differ 9(12):1007–1014PubMed Vanacker JM, Delmarre C, Guo X, Laudet V (1998) Activation of the osteopontin promoter by the orphan nuclear receptor estrogen receptor related alpha. Cell Growth Differ 9(12):1007–1014PubMed
Metadata
Title
The Unexplained Female Predominance of Systemic Lupus Erythematosus: Clues from Genetic and Cytokine Studies
Authors
Corinna E. Weckerle
Timothy B. Niewold
Publication date
01-02-2011
Publisher
Humana Press Inc
Published in
Clinical Reviews in Allergy & Immunology / Issue 1/2011
Print ISSN: 1080-0549
Electronic ISSN: 1559-0267
DOI
https://doi.org/10.1007/s12016-009-8192-4

Other articles of this Issue 1/2011

Clinical Reviews in Allergy & Immunology 1/2011 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.